Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry

PURPOSE: Anti-estrogen therapy may be used as a palliative treatment option in high-grade serous ovarian carcinomas (HGSC). However, clinical implementation is limited as the use of estrogen receptor (ER) protein expression by immunohistochemistry remains insufficient in predicting therapy response....

Descripción completa

Detalles Bibliográficos
Autores principales: van der Ploeg, Phyllis, van Lieshout, Laura A. M., van de Stolpe, Anja, Bosch, Steven L., Lentjes-Beer, Marjolein H. F. M., Bekkers, Ruud L. M., Piek, Jurgen M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338831/
https://www.ncbi.nlm.nih.gov/pubmed/33723801
http://dx.doi.org/10.1007/s13402-021-00600-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338831/
https://www.ncbi.nlm.nih.gov/pubmed/33723801
http://dx.doi.org/10.1007/s13402-021-00600-5

Ejemplares similares